PCT

ANALYST NOTE: PURECYCLE TECHNOLOGIES, INC. (PCT) DATE: 2026-06-13 CURRENT PRICE: $8.70

1. Structural Readiness

• State: Forming.
• Conservative Entry: Not yet actionable. A conservative entry requires a confirmed breakout above the established resistance structure.
• Aggressive/Pre-Breakout Entry: Not recommended for standard execution; the setup is incomplete.
• Breakout Level: Pending confirmation.
• Current Price: $8.70.
• Extension: Not applicable (price is not in an extended breakout phase).
• ATR Context: Current ATR is 10.6% (Extreme). This indicates severe volatility and elevated risk for position sizing, consistent with the "extreme" bucket which historically correlates with higher severe-loser rates if the setup fails.

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Context: There is NO named secular thesis attached to this name as of 2026-06-13. The investment case is not driven by a broad macro theme (e.g., "Green Energy Super-Cycle") but is strictly dependent on the quality of the technical setup and the execution of specific business fundamentals.
• Judgment Criteria: The name must be judged solely on the integrity of the structural setup (the coil) and the verifiable progress of the business model as reported in the evidence base. No external thesis should be invented to bolster conviction.

3. Business Fundamentals

PureCycle Technologies, Inc. is a Florida-based corporation focused on commercializing a patented dissolution recycling technology for polypropylene. The technology physically separates the polymer from impurities, colors, and odors to produce "PureFive®" resin, which is designed to be like-new virgin polypropylene.

Operational Progress (as of Q1 2026 / May 2026):

• Production Volume: The Ironton facility produced 8.4 million pounds of PureFive in Q1 2026, representing a 12% sequential increase from Q4 2025.
• Revenue Growth: The company booked $4.1 million in revenue for the quarter, marking the fifth consecutive quarter of sequential growth, exceeding internal expectations.
• Customer & Pricing: Eight new customers were converted in Q1. Management reports that branded pricing is "robust and above internal targets."
• Commercialization Milestones:
• P&G Applications: Final approval was achieved for two Procter & Gamble applications. Tide caps for select bottles began shipping in Q2 2026, with Vicks ZzzQuil caps scheduled for the second half of 2026.
• Market Ramps: Management expects branded applications with 40–50 million pounds of annual demand to ramp in Q2 and Q3 2026. An additional 20–25 million pounds of application capacity is expected to ramp in Q3 and Q4 2026.
• Pipeline: The active opportunity pipeline stands at approximately 180, up from 170 at year-end 2025 and 100 a year prior.

Capital & Legal Status:

• Thailand Facility: On March 1, 2026, the company entered a 30-year land lease agreement with IRPC Public Company Limited in Rayong, Thailand, to construct a new recycling facility.
• EU Funding: An application for a €40 million grant from the EU Innovation Fund was accepted in November 2025. The agreement was expected to be negotiated and executed in the first half of 2026 to fund the Belgium Facility.
• Legal Resolution: Following an arbitration decision in November 2025, a Final Order on March 18, 2026, required the company to pay DB approximately $20.3 million (including fees and interest), a reduction from the initial $17 million demand plus interest.
• Licensing: The company holds a global license from P&G, amended in 2025 to permanently waive clawback risks for North American plants and extend construction timelines for other regions.

4. Archetype and Conviction

• Archetype: Growth Leader / Margin Inflector.
• The company is transitioning from a pre-revenue/early-revenue stage to a commercial operator with sequential revenue growth and expanding branded mix. The "margin inflector" aspect is driven by the "robust" pricing and the shift toward higher-margin branded applications (P&G) rather than commodity sales.
• Valuation Context: No explicit valuation multiples (P/E, EV/EBITDA) are provided in the evidence base for 2026. The focus remains on the trajectory of revenue growth and the ramp of specific volume targets.
• Conviction Stack:
• Thesis Strength: Low (No macro thesis; purely tactical).
• Evidence Quality: High. The evidence base is dense with specific, quantifiable milestones (8.4M lbs, $4.1M revenue, specific P&G approvals, legal resolution).
• Structural Quality: Moderate/Positive. The setup is "Forming," meaning the structure is intact but unconfirmed. The extreme ATR (10.6%) suggests high volatility, which increases the risk of a false breakout or a sharp invalidation if the setup fails.
• Setup Readiness: Incomplete. The setup requires a breakout to be actionable.
• Rerating Potential: Dependent on the successful execution of the Q2/Q3 volume ramps and the realization of the Thailand and Belgium facilities.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• A significant miss on the Q2/Q3 volume ramp targets (40-50M lbs branded demand).
• Failure to secure the EU grant funding or delays in the Thailand/Belgium construction that jeopardize the 2026/2027 timeline.
• A reversal in the "robust" branded pricing environment.
• What Would Strengthen:
• A confirmed breakout above the resistance structure (firing the coil).
• Confirmation of the EU grant execution and finalization of the Thailand lease construction start.
• Further sequential revenue growth exceeding the $4.1M Q1 baseline.
• Expansion of the P&G application list beyond the two currently approved.
• Gaps in Evidence:
• Cash Position: No explicit data on current cash runway or burn rate as of June 2026 is provided, which is critical given the capital-intensive nature of building new facilities (Thailand/Belgium).
• Profitability: While revenue is growing, there is no explicit data on EBITDA or net income status (break-even timeline).
• Capex Specifics: While the EU grant is mentioned, the total capital expenditure required for the Thailand and Belgium facilities is not quantified in the provided text.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Fifth consecutive quarter of sequential revenue growth ($4.1M Q1); 8.4M lbs production in Q1 with 12% sequential increase; Final approval for two major P&G applications (Tide/Vicks) with shipping commencing in Q2. Key risks: Extreme ATR (10.6%) indicating high volatility and severe-loser risk; Pending $20.3M legal payment obligation; Capital intensity of new Thailand/Belgium facilities without explicit cash runway data; Setup is "Forming" and not yet confirmed. Sizing hint: Position size must be significantly reduced due to extreme volatility and unconfirmed setup; treat as a satellite holding only if the breakout fires. Expected path: Management expects branded volume ramps of 40-50M lbs in Q2/Q3 and 20-25M lbs in Q3/Q4; successful execution of these ramps should drive the price toward a breakout confirmation. Expected horizon: 3 to 6 months for the Q2/Q3 ramp data to validate the setup and potentially trigger a breakout.